Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

The team tested mvGPT on human liver cells with a mutation causing Wilson's disease, successfully editing out the mutation while also upregulating a gene linked to type I diabetes treatment and ...

Zhang, an MIT professor and a pioneer in gene-editing technology ... of treatments for sickle cell disease, cancer, type 1 diabetes, and more,” it said. Established by Congress in 1980, the ...